FeesSafety
Pluang+

Rigel Pharmaceuticals grants 35,275 restricted stock units to 18 new employees as an inducement.

Company Fundamentals
02 Oct 2026, 15:05 WIB
PRNewsWire
View Source
Neutral
Rigel Pharmaceuticals grants 35,275 restricted stock units to 18 new employees as an inducement.

Rigel Pharmaceuticals has awarded 35,275 restricted stock units to 18 non-executive employees under its Inducement Plan. These stock units will vest over four years, with 25% vesting each year. This move is designed to attract and retain talent as part of Rigel's ongoing efforts to support its growth in developing therapies for hematologic disorders and cancer. The company is based in South San Francisco and continues to focus on innovative biotechnology solutions.

Rigel Pharmaceuticals' inducement grants provide context for the health sector's market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 02, 2026 16:41 WIB: 66 out of 100 priced health-sector US stocks rose today. Notable movers include CRSP at USD 56.10 with a 1-day change of +1.19%, NVS at USD 142.69 with a 1-day change of +1.16%, and SNN at USD 26.30 with a 1-day change of -1.05%.

More News

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs forecasts S&P 500 to rise 26% to 8,700 by late 2027 amid tech stock value rebound.

Goldman Sachs predicts the S&P 500 will climb about 26% to 8,700 points within the next 12 months, despite recent market volatility and concerns over AI-driven tech investments. The forecast is supported by lower valuations in tech stocks and a forwa...

Bullish
59 minutes ago
S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

S&P 500 nearly quadrupled investments in 10 years despite recent pullbacks, driven by rising corporate profits.

Over the past decade, the S&P 500 index has risen 229%, turning a $1,000 investment into nearly $4,000, mainly due to a 212% increase in corporate earnings rather than valuation changes. Despite recent market drops and volatility, holding through pul...

Bullish
1 hour ago
Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb offers a 4.3% yield with strong new drug growth despite upcoming patent risks.

Bristol Myers Squibb, a major pharmaceutical company, currently offers a 4.3% dividend yield and trades at a price-to-earnings ratio well below the industry average. Its newer drug portfolio generated nearly $7.7 billion in revenue last quarter, grow...

Market News
Bullish
1 hour ago
Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia stock plunges 43% after CEO Jensen Huang resigns amid scandal, but analyst sees 65% upside ahead.

Nvidia's stock has dropped about 43% following CEO Jensen Huang's sudden resignation linked to alleged Chinese intelligence ties, wiping out over $2.5 trillion in market value. Despite concerns about leadership loss, analyst Dan Ives believes Nvidia'...

Market News
Bearish
1 hour ago
ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS launches holiday sale with up to 44% off laptops and desktops until Dec 2, 2026

ASUS has announced a holiday sale offering discounts up to 44% on a wide range of laptops and desktops, available online and in stores like Best Buy until December 2, 2026. The sale features budget-friendly options like the ASUS Vivobook 14 starting ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App